Annual EBITDA
-$6.86 M
-$4.54 M-196.02%
31 December 2023
Summary:
Chromocell Therapeutics annual earnings before interest, taxes, depreciation & amortization is currently -$6.86 million, with the most recent change of -$4.54 million (-196.02%) on 31 December 2023. During the last 3 years, it has fallen by -$6.27 million (-1053.13%). CHRO annual EBITDA is now -1053.13% below its all-time high of -$595.10 thousand, reached on 01 December 2021.CHRO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$2.02 M
-$258.17 K-14.66%
30 September 2024
Summary:
Chromocell Therapeutics quarterly earnings before interest, taxes, depreciation & amortization is currently -$2.02 million, with the most recent change of -$258.17 thousand (-14.66%) on 30 September 2024. Over the past year, it has increased by +$1.86 million (+47.96%). CHRO quarterly EBITDA is now -861.30% below its all-time high of -$210.00 thousand, reached on 01 December 2021.CHRO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$9.59 M
-$727.03 K-8.20%
30 September 2024
Summary:
Chromocell Therapeutics TTM earnings before interest, taxes, depreciation & amortization is currently -$9.59 million, with the most recent change of -$727.03 thousand (-8.20%) on 30 September 2024. Over the past year, it has dropped by -$2.73 million (-39.78%). CHRO TTM EBITDA is now -4467.66% below its all-time high of -$210.00 thousand, reached on 01 December 2021.CHRO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CHRO EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +48.0% | -39.8% |
| 3 y3 years | -1053.1% | -861.3% | -4467.7% |
| 5 y5 years | - | - | - |
CHRO EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1053.1% | at low | -861.3% | +48.0% | -4467.7% | at low |
| 5 y | 5 years | -1053.1% | at low | -861.3% | +48.0% | -4467.7% | at low |
| alltime | all time | -1053.1% | at low | -861.3% | +48.0% | -4467.7% | at low |
Chromocell Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2.02 M(+14.7%) | -$9.59 M(+8.2%) |
| June 2024 | - | -$1.76 M(-9.0%) | -$8.87 M(+12.5%) |
| Mar 2024 | - | -$1.93 M(-50.1%) | -$7.88 M(+14.9%) |
| Dec 2023 | -$6.86 M | -$3.88 M(+200.3%) | -$6.86 M(+63.5%) |
| Sept 2023 | - | -$1.29 M(+66.2%) | -$4.20 M(+22.6%) |
| June 2023 | - | -$777.20 K(-15.0%) | -$3.43 M(+16.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$914.60 K(-24.7%) | -$2.94 M(+27.0%) |
| Dec 2022 | -$2.32 M(+289.5%) | -$1.21 M(+134.2%) | -$2.32 M(+76.5%) |
| Sept 2022 | - | -$518.80 K(+74.9%) | -$1.31 M(+65.3%) |
| June 2022 | - | -$296.70 K(+3.1%) | -$794.50 K(+59.6%) |
| Mar 2022 | - | -$287.80 K(+37.0%) | -$497.80 K(+137.0%) |
| Dec 2021 | -$595.10 K(-9.7%) | -$210.00 K | -$210.00 K |
| Dec 2020 | -$658.90 K | - | - |
FAQ
- What is Chromocell Therapeutics annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Chromocell Therapeutics?
- What is Chromocell Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Chromocell Therapeutics?
- What is Chromocell Therapeutics quarterly EBITDA year-on-year change?
- What is Chromocell Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Chromocell Therapeutics?
- What is Chromocell Therapeutics TTM EBITDA year-on-year change?
What is Chromocell Therapeutics annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of CHRO is -$6.86 M
What is the all time high annual EBITDA for Chromocell Therapeutics?
Chromocell Therapeutics all-time high annual earnings before interest, taxes, depreciation & amortization is -$595.10 K
What is Chromocell Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of CHRO is -$2.02 M
What is the all time high quarterly EBITDA for Chromocell Therapeutics?
Chromocell Therapeutics all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$210.00 K
What is Chromocell Therapeutics quarterly EBITDA year-on-year change?
Over the past year, CHRO quarterly earnings before interest, taxes, depreciation & amortization has changed by +$1.86 M (+47.96%)
What is Chromocell Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of CHRO is -$9.59 M
What is the all time high TTM EBITDA for Chromocell Therapeutics?
Chromocell Therapeutics all-time high TTM earnings before interest, taxes, depreciation & amortization is -$210.00 K
What is Chromocell Therapeutics TTM EBITDA year-on-year change?
Over the past year, CHRO TTM earnings before interest, taxes, depreciation & amortization has changed by -$2.73 M (-39.78%)